Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › MiRNAs dysregulated in triple-negative breast cancer

MiRNAs dysregulated in triple-negative breast cancer

US Patent 8507195 · Granted Aug 13, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

FKBP52 specific androgen receptor inhibitor, MJC13, for use in treating breast c2019
Treatment of breast cancer2018
Treatment of breast cancer2018
Importing accounting application data into a tax preparation application2018
Treatment of breast cancer2016
Treatment of breast cancer2016
Tissue-treatment methods2016
Importing accounting application data into a tax preparation application2013
Tissue-treatment methods2013
Modular individual wastewater nutrient removal system2012
Carbon-based biofilm carrier2012
Intravascular catheter with composite reinforcement2011